Will this Chinese-engineered ‘bacterial assassin’ transform cancer treatment?
Synthetic ‘kill switch’ could fast track new immunotherapies, turning bacterial armies against cancer tumours, study shows.
MIT Technology Review6m
Now read the rest of The Algorithm
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection. What will really matter in the long run? That’s the question we tackle each year as ...